These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 28679390)
1. LncRNA-ANCR regulates the cell growth of osteosarcoma by interacting with EZH2 and affecting the expression of p21 and p27. Zhang F; Peng H J Orthop Surg Res; 2017 Jul; 12(1):103. PubMed ID: 28679390 [TBL] [Abstract][Full Text] [Related]
2. LncRNA ANCR promotes glioma cells invasion, migration, proliferation and inhibits apoptosis via interacting with EZH2 and repressing PTEN expression. Cheng C; Dong Y; Ru X; Xia Y; Ji Y Cancer Gene Ther; 2021 Sep; 28(9):1025-1034. PubMed ID: 33293663 [TBL] [Abstract][Full Text] [Related]
3. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer. Li Z; Hou P; Fan D; Dong M; Ma M; Li H; Yao R; Li Y; Wang G; Geng P; Mihretab A; Liu D; Zhang Y; Huang B; Lu J Cell Death Differ; 2017 Jan; 24(1):59-71. PubMed ID: 27716745 [TBL] [Abstract][Full Text] [Related]
4. Silencing of LncRNA-ANCR Promotes the Osteogenesis of Osteoblast Cells in Postmenopausal Osteoporosis via Targeting EZH2 and RUNX2. Cai N; Li C; Wang F Yonsei Med J; 2019 Aug; 60(8):751-759. PubMed ID: 31347330 [TBL] [Abstract][Full Text] [Related]
5. LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression. Yang ZY; Yang F; Zhang YL; Liu B; Wang M; Hong X; Yu Y; Zhou YH; Zeng H Cancer Biomark; 2017; 18(1):95-104. PubMed ID: 27983539 [TBL] [Abstract][Full Text] [Related]
6. Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression. Zhu L; Xu PC Biochem Biophys Res Commun; 2013 Mar; 432(4):612-7. PubMed ID: 23438432 [TBL] [Abstract][Full Text] [Related]
7. Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway. Liu B; Zhao H; Zhang L; Shi X BMC Cancer; 2019 Nov; 19(1):1112. PubMed ID: 31727012 [TBL] [Abstract][Full Text] [Related]
8. HIF-1α induced long noncoding RNA FOXD2-AS1 promotes the osteosarcoma through repressing p21. Ren Z; Hu Y; Li G; Kang Y; Liu Y; Zhao H Biomed Pharmacother; 2019 Sep; 117():109104. PubMed ID: 31228799 [TBL] [Abstract][Full Text] [Related]
9. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2. Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193 [TBL] [Abstract][Full Text] [Related]
10. Antidifferentiation Noncoding RNA Regulates the Proliferation of Osteosarcoma Cells. Min L; Hong S; Duan H; Zhou Y; Zhang W; Luo Y; Shi R; Tu C Cancer Biother Radiopharm; 2016 Mar; 31(2):52-7. PubMed ID: 26986815 [TBL] [Abstract][Full Text] [Related]
11. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2. Wang X; Sehgal L; Jain N; Khashab T; Mathur R; Samaniego F J Transl Med; 2016 Dec; 14(1):346. PubMed ID: 27998273 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of antidifferentiation noncoding RNA promotes chondrogenic differentiation and calcification of ligamentum flavum-derived mesenchymal stem cells. Zhang Q; Wang S; Sheng Y; Zhao S; Jiang Y; Zhou D; Yang H J Cell Biochem; 2019 Mar; 120(3):3401-3414. PubMed ID: 30368870 [TBL] [Abstract][Full Text] [Related]
13. LncRNA-p21 inhibited the proliferation of osteosarcoma cells via the miR-130b/PTEN/AKT signaling pathway. Han W; Liu J Biomed Pharmacother; 2018 Jan; 97():911-918. PubMed ID: 29136769 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of ZEB2-AS1 inhibits cell proliferation, invasion and induces apoptosis in osteosarcoma by combining with EZH2. Zhang B; Fan DB; Liu L; Qin Y; Feng DQ Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6533-6539. PubMed ID: 32633340 [TBL] [Abstract][Full Text] [Related]
15. The carcinogenic complex lncRNA DUXAP8/EZH2/LSD1 accelerates the proliferation, migration and invasion of colorectal cancer. Gong A; Huang Z; Ge H; Cai Y; Yang C J BUON; 2019; 24(5):1830-1836. PubMed ID: 31786844 [TBL] [Abstract][Full Text] [Related]
16. LncRNA ANCR Promotes Invasion and Migration of Gastric Cancer by Regulating FoxO1 Expression to Inhibit Macrophage M1 Polarization. Xie C; Guo Y; Lou S Dig Dis Sci; 2020 Oct; 65(10):2863-2872. PubMed ID: 31894487 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2. Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259 [TBL] [Abstract][Full Text] [Related]
18. LINC00313 facilitates osteosarcoma carcinogenesis and metastasis through enhancing EZH2 mRNA stability and EZH2-mediated silence of PTEN expression. Xing CY; Zhang YZ; Hu W; Zhao LY Cell Mol Life Sci; 2022 Jun; 79(7):382. PubMed ID: 35751755 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR). Zhou Q; Chen J; Feng J; Wang J Tumour Biol; 2016 Mar; 37(3):3105-13. PubMed ID: 26427660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]